Frank Kalkbrenner (Boehringer Ingelheim Venture Fund (BIVF))

Kalkbrenner, Frank (Boehringer 201308 CVP + Head of BIVF + CEO Acousia Therapeutics GmbH)

	Organisation	Boehringer Ingelheim Venture Fund (BIVF)
	Former/major organisation	Acousia Therapeutics GmbH
	Product	venture capital
	Product 2	drug development

Record changed: 2020-08-06

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Frank Kalkbrenner

[1] T3 Pharmaceuticals AG. (7/22/20). "Press Release: T3 Pharma Raises 25M CHF to Advance Bacterial Cancer Therapy through Clinic". Basel....
[2] T3 Pharmaceuticals AG. (9/26/19). "Press Release: Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic"....
[3] High-Tech Gründerfonds Management GmbH. (5/29/18). "Press Release: Bayer and Boehringer Ingelheim Invest in HTGF III"....
[4] Brainomix Ltd.. (4/3/18). "Press Release: Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes with AI". Oxford....
[5] Boehringer Ingelheim. (1/3/18). "Press Release: Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€". Ingelheim & Boston, MA....
[6] Amal Therapeutics S.A.. (3/30/16). "Press Release: Amal Therapeutics Raises CHF 3 Million in a Series A Financing Round Led by Boehringer Ingelheim Venture Fund". Geneva & Ingelheim....
[7] Boehringer Ingelheim. (3/30/16). "Press Release: Boehringer Ingelheim Venture Fund Invests in Amal Therapeutics to Develop Novel Therapeutic Colorectal Cancer Vaccine". Ingelheim & Geneva....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

Frank Kalkbrenner (Boehringer Ingelheim Venture Fund (BIVF))

More documents for Frank Kalkbrenner